Standard Chartered Denies Derivatives Sales Lapses Amid RBI Scrutiny
Standard Chartered denied any breaches in its derivatives sales processes following a report that the Reserve Bank of India was examining the bank's sales practices to small and medium-sized enterprises regarding complex financial products that could incur substantial losses.

Standard Chartered has firmly denied any lapses in its sales of derivative products, amid reports of scrutiny by the Reserve Bank of India (RBI). The denial follows a Bloomberg News report claiming the RBI raised concerns over sales to small and medium-sized enterprises.
The controversy centers around target redemption forwards, a derivative product potentially leading to substantial losses. The report suggested that buyers were not properly informed about the risks. In response, Standard Chartered's spokesperson refuted Bloomberg's claims, labeling them speculative and inaccurate.
According to the bank, all structured products are offered only to eligible clients, maintaining high standards of compliance, transparency, and customer focus. The RBI has not commented on the matter as of now.
(With inputs from agencies.)
ALSO READ
Expect India-US trade deal in not too distant future: US Commerce Secretary Howard Lutnick
Expect India-US trade deal in not too distant future: US Commerce Secretary Howard Lutnick
A Vision from the Frontlines of Shekar Hospital reimagines Universal Insurance for India’s growing demand for quality healthcare.
Expect India-US trade deal in not-too-distant future: US Commerce Secretary Howard Lutnick
"Trip of a lifetime, meeting PM Modi was very special": US Second Lady Usha Vance recalls India visit and her children's experience